APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Influenza Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Swine Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchSwine Influenza Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Influenza Vaccines Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Swine Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Influenza Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Influenza Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Swine Influenza Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Swine Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Swine Influenza Vaccines include Boehringer Ingelheim, CAHIC, Ceva, DHN, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Ringpu Biology and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Swine Influenza Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Influenza Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Influenza Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Influenza Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Influenza Vaccines Segment by Company

Boehringer Ingelheim

CAHIC

Ceva

DHN

Green Cross Veterinary

Hipra

MSD Animal Health (Merck)

Ringpu Biology

Zoetis

Chengdu TECBOND

Swine Influenza Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Swine Influenza Vaccines Segment by Application

Commodity Pig

Breeding Pig

Swine Influenza Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Influenza Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Swine Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Swine Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Swine Influenza Vaccines Industry Trends Table 2. Swine Influenza Vaccines Industry Drivers Table 3. Swine Influenza Vaccines Industry Opportunities and Challenges Table 4. Swine Influenza Vaccines Industry Restraints Table 5. Global Swine Influenza Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Swine Influenza Vaccines Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Swine Influenza Vaccines Sales Market Share by Manufacturers Table 9. Global Swine Influenza Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Swine Influenza Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Swine Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Swine Influenza Vaccines Manufacturers, Product Type & Application Table 13. Global Swine Influenza Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Influenza Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Vaccines Table 17. Major Manufacturers of Killed Vaccines Table 18. Global Swine Influenza Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 19. Global Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 20. Global Swine Influenza Vaccines Sales by Type (2027-2032) & (M Units) Table 21. Global Swine Influenza Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Swine Influenza Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Swine Influenza Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Swine Influenza Vaccines Revenue by Type (2021-2026) & (M Units) Table 25. Global Swine Influenza Vaccines Revenue by Type (2027-2032) & (M Units) Table 26. Global Swine Influenza Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Swine Influenza Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Commodity Pig Table 29. Major Manufacturers of Breeding Pig Table 30. Global Swine Influenza Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 31. Global Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 32. Global Swine Influenza Vaccines Sales by Application (2027-2032) & (M Units) Table 33. Global Swine Influenza Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Swine Influenza Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Swine Influenza Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 36. Global Swine Influenza Vaccines Revenue by Application (2021-2026) & (M Units) Table 37. Global Swine Influenza Vaccines Revenue by Application (2027-2032) & (M Units) Table 38. Global Swine Influenza Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Swine Influenza Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Swine Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 41. Global Swine Influenza Vaccines Sales by Region (2021-2026) & (M Units) Table 42. Global Swine Influenza Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Swine Influenza Vaccines Sales Forecasted by Region (2027-2032) & (M Units) Table 44. Global Swine Influenza Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Swine Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 46. North America Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 47. North America Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 48. Europe Swine Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 49. Europe Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 50. Europe Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 51. Asia Pacific Swine Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 52. Asia Pacific Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 53. Asia Pacific Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 54. South America, Middle East and Africa Swine Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. South America, Middle East and Africa Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 56. South America, Middle East and Africa Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 57. Global Swine Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Swine Influenza Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Swine Influenza Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Swine Influenza Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Swine Influenza Vaccines Revenue Market Share by Region (2027-2032) Table 62. Boehringer Ingelheim Company Information Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio Table 66. Boehringer Ingelheim Recent Development Table 67. CAHIC Company Information Table 68. CAHIC Business Overview Table 69. CAHIC Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. CAHIC Swine Influenza Vaccines Product Portfolio Table 71. CAHIC Recent Development Table 72. Ceva Company Information Table 73. Ceva Business Overview Table 74. Ceva Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Ceva Swine Influenza Vaccines Product Portfolio Table 76. Ceva Recent Development Table 77. DHN Company Information Table 78. DHN Business Overview Table 79. DHN Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. DHN Swine Influenza Vaccines Product Portfolio Table 81. DHN Recent Development Table 82. Green Cross Veterinary Company Information Table 83. Green Cross Veterinary Business Overview Table 84. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Green Cross Veterinary Swine Influenza Vaccines Product Portfolio Table 86. Green Cross Veterinary Recent Development Table 87. Hipra Company Information Table 88. Hipra Business Overview Table 89. Hipra Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Hipra Swine Influenza Vaccines Product Portfolio Table 91. Hipra Recent Development Table 92. MSD Animal Health (Merck) Company Information Table 93. MSD Animal Health (Merck) Business Overview Table 94. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio Table 96. MSD Animal Health (Merck) Recent Development Table 97. Ringpu Biology Company Information Table 98. Ringpu Biology Business Overview Table 99. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Ringpu Biology Swine Influenza Vaccines Product Portfolio Table 101. Ringpu Biology Recent Development Table 102. Zoetis Company Information Table 103. Zoetis Business Overview Table 104. Zoetis Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Zoetis Swine Influenza Vaccines Product Portfolio Table 106. Zoetis Recent Development Table 107. Chengdu TECBOND Company Information Table 108. Chengdu TECBOND Business Overview Table 109. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Chengdu TECBOND Swine Influenza Vaccines Product Portfolio Table 111. Chengdu TECBOND Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Swine Influenza Vaccines Distributors List Table 115. Swine Influenza Vaccines Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Swine Influenza Vaccines Product Image Figure 2. Global Swine Influenza Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Influenza Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Influenza Vaccines Sales (2021-2032) & (M Units) Figure 5. Global Swine Influenza Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Swine Influenza Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Vaccines Image Figure 9. Killed Vaccines Image Figure 10. Global Swine Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 11. Global Swine Influenza Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Swine Influenza Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Swine Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Swine Influenza Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Swine Influenza Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Commodity Pig Image Figure 17. Breeding Pig Image Figure 18. Global Swine Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 19. Global Swine Influenza Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Swine Influenza Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Swine Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Swine Influenza Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Swine Influenza Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 25. North America Swine Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 27. Canada Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Mexico Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Europe Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Swine Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 32. France Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 33. U.K. Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Italy Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Netherlands Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Asia Pacific Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Swine Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Japan Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 40. South Korea Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Southeast Asia Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 42. India Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Australia Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 44. South America, Middle East and Africa Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Swine Influenza Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South Africa Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 48. Saudi Arabia Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Turkey Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Argentina Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 51. UAE Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Egypt Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Chile Swine Influenza Vaccines Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Global Swine Influenza Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Swine Influenza Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Swine Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Swine Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Swine Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Swine Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Swine Influenza Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Swine Influenza Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Commodity Pig
  • Breeding Pig
Companies covered
  • Boehringer Ingelheim
  • CAHIC
  • Ceva
  • DHN
  • Green Cross Veterinary
  • Hipra
  • MSD Animal Health (Merck)
  • Ringpu Biology
  • Zoetis
  • Chengdu TECBOND

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Swine Influenza Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Swine Influenza Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Swine Influenza Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Swine Influenza Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Swine Influenza Vaccines Market Dynamics
  1. 2.1 Swine Influenza Vaccines Industry Trends
  2. 2.2 Swine Influenza Vaccines Industry Drivers
  3. 2.3 Swine Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Influenza Vaccines Industry Restraints
3 Swine Influenza Vaccines Market by Manufacturers
  1. 3.1 Global Swine Influenza Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Swine Influenza Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Swine Influenza Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Swine Influenza Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Swine Influenza Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Swine Influenza Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Influenza Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Influenza Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Influenza Vaccines Tier 1, Tier 2, and Tier 3
4 Swine Influenza Vaccines Market by Type
  1. 4.1 Swine Influenza Vaccines Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Swine Influenza Vaccines Sales by Type
  5. 4.2.1 Global Swine Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Swine Influenza Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Swine Influenza Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Swine Influenza Vaccines Revenue by Type
  9. 4.3.1 Global Swine Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Swine Influenza Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Swine Influenza Vaccines Revenue Market Share by Type (2021-2032)
5 Swine Influenza Vaccines Market by Application
  1. 5.1 Swine Influenza Vaccines Application Introduction
  2. 5.1.1 Commodity Pig
  3. 5.1.2 Breeding Pig
  4. 5.2 Global Swine Influenza Vaccines Sales by Application
  5. 5.2.1 Global Swine Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Influenza Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Swine Influenza Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Swine Influenza Vaccines Revenue by Application
  9. 5.3.1 Global Swine Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Influenza Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Swine Influenza Vaccines Revenue Market Share by Application (2021-2032)
6 Global Swine Influenza Vaccines Sales by Region
  1. 6.1 Global Swine Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Influenza Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Influenza Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Swine Influenza Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Swine Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Swine Influenza Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Swine Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Swine Influenza Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Swine Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Swine Influenza Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Swine Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Swine Influenza Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Swine Influenza Vaccines Revenue by Region
  1. 7.1 Global Swine Influenza Vaccines Revenue by Region
  2. 7.1.1 Global Swine Influenza Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Swine Influenza Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Swine Influenza Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Swine Influenza Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Swine Influenza Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Swine Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Swine Influenza Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Swine Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Swine Influenza Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Swine Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Swine Influenza Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Swine Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 CAHIC
  8. 8.2.1 CAHIC Company Information
  9. 8.2.2 CAHIC Business Overview
  10. 8.2.3 CAHIC Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CAHIC Swine Influenza Vaccines Product Portfolio
  12. 8.2.5 CAHIC Recent Developments
  13. 8.3 Ceva
  14. 8.3.1 Ceva Company Information
  15. 8.3.2 Ceva Business Overview
  16. 8.3.3 Ceva Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Swine Influenza Vaccines Product Portfolio
  18. 8.3.5 Ceva Recent Developments
  19. 8.4 DHN
  20. 8.4.1 DHN Company Information
  21. 8.4.2 DHN Business Overview
  22. 8.4.3 DHN Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DHN Swine Influenza Vaccines Product Portfolio
  24. 8.4.5 DHN Recent Developments
  25. 8.5 Green Cross Veterinary
  26. 8.5.1 Green Cross Veterinary Company Information
  27. 8.5.2 Green Cross Veterinary Business Overview
  28. 8.5.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Green Cross Veterinary Swine Influenza Vaccines Product Portfolio
  30. 8.5.5 Green Cross Veterinary Recent Developments
  31. 8.6 Hipra
  32. 8.6.1 Hipra Company Information
  33. 8.6.2 Hipra Business Overview
  34. 8.6.3 Hipra Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hipra Swine Influenza Vaccines Product Portfolio
  36. 8.6.5 Hipra Recent Developments
  37. 8.7 MSD Animal Health (Merck)
  38. 8.7.1 MSD Animal Health (Merck) Company Information
  39. 8.7.2 MSD Animal Health (Merck) Business Overview
  40. 8.7.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio
  42. 8.7.5 MSD Animal Health (Merck) Recent Developments
  43. 8.8 Ringpu Biology
  44. 8.8.1 Ringpu Biology Company Information
  45. 8.8.2 Ringpu Biology Business Overview
  46. 8.8.3 Ringpu Biology Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ringpu Biology Swine Influenza Vaccines Product Portfolio
  48. 8.8.5 Ringpu Biology Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Swine Influenza Vaccines Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
  55. 8.10 Chengdu TECBOND
  56. 8.10.1 Chengdu TECBOND Company Information
  57. 8.10.2 Chengdu TECBOND Business Overview
  58. 8.10.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu TECBOND Swine Influenza Vaccines Product Portfolio
  60. 8.10.5 Chengdu TECBOND Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Influenza Vaccines Value Chain Analysis
  2. 9.1.1 Swine Influenza Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Influenza Vaccines Production Mode & Process
  6. 9.2 Swine Influenza Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Influenza Vaccines Distributors
  9. 9.2.3 Swine Influenza Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst